New Regional Certifications to Boost Healthcare Training Standards Across Southeast Asia

New Regional Certifications to Boost Healthcare Training Standards Across Southeast Asia

Two new specially designed certification programmes will train doctors, nurses and technical specialists across the region in simulation-based medical education. SINGAPORE, Nov. 6, 2025 /PRNewswire/ -- The first healthcare simulation certification...

Rocket Travel by Agoda Launches the Loyalty Value Playbook to Help Travel Leaders Stay Ahead of the Loyalty Game

Rocket Travel by Agoda Launches the Loyalty Value Playbook to Help Travel Leaders Stay Ahead of the Loyalty Game

The new report by Rocket Travel by Agoda and Skift reveals framework for brands to close the loyalty value gap with seamless redemptions and cash spend SINGAPORE, Nov. 6, 2025 /PRNewswire/ -- As customer expectations rapidly evolve, their perception...

Nel ASA: Receives PEM purchase order from the HyFuel and Kaupanes hydrogen projects valued at more than USD 50 million

Nel ASA: Receives PEM purchase order from the HyFuel and Kaupanes hydrogen projects valued at more than USD 50 million

OSLO, Norway, Nov. 6, 2025 /PRNewswire/ -- Nel Hydrogen US, a subsidiary of Nel ASA (Nel) (OSE: NEL), has received a firm purchase order from Kaupanes Hydrogen AS and HyFuel AS in Norway. Both are developed by Hydrogen Solutions AS (HYDS) in close...

WIRobotics' Walking-Assist Wearable Robot "WIM KIDS" Wins CES 2026 Innovation Award in Digital Health

WIRobotics' Walking-Assist Wearable Robot "WIM KIDS" Wins CES 2026 Innovation Award in Digital Health

A Step Toward Growth: WIM KIDS, the Wearable Robot That Accompanies a Child's Journey SEOUL, South Korea, Nov. 6, 2025 /PRNewswire/ -- Global wearable robotics company WIRobotics (Co-CEOs Yeonbaek Lee and Yongjae Kim, Professor at Korea University...

Miroma Project Factory's Avow App Leads the Way in Tech-Driven Domestic Violence Prevention

Miroma Project Factory's Avow App Leads the Way in Tech-Driven Domestic Violence Prevention

SYDNEY, Nov. 5, 2025 /PRNewswire/ -- Miroma Project Factory (MPF) has re-launched an updated and re-designed version of Avow, Australia's first digital tool designed specifically to support individuals who use violence, helping them understand...

LANZAJET ANNOUNCES SELECTION OF FLUOR CORPORATION FOR FRONT-END ENGINEERING AND DESIGN (FEED) FOR PROJECT SPEEDBIRD - LANZAJET'S FLAGSHIP UK SAF PLANT

LANZAJET ANNOUNCES SELECTION OF FLUOR CORPORATION FOR FRONT-END ENGINEERING AND DESIGN (FEED) FOR PROJECT SPEEDBIRD - LANZAJET'S FLAGSHIP UK SAF PLANT

CHICAGO, Nov. 4, 2025 /PRNewswire/ -- LanzaJet, Inc., a leading next-gen fuels technology company and producer of sustainable fuels, has recently awarded the Front-End Engineering and Design (FEED) for Project Speedbird to Fluor Corporation (NYSE:...

Japan's Flying Sports Car "STAR WALKERS," Developed by World Scan Project Corporation, Takes off -- Reservations Open October 16

Japan's Flying Sports Car "STAR WALKERS," Developed by World Scan Project Corporation, Takes off -- Reservations Open October 16

- Made-in-Japan Marvel, with Compact, Van-sized Design, Turned Heads at Unveiling Event, Redefining Future of Mobility and Design - TOKYO, Nov. 4, 2025 /PRNewswire/ -- World Scan Project Corporation (hereafter "WSP"), a subsidiary of World Scan...

CARsgen Announces Positive Clinical Data for Allogeneic CAR-T Products CT0596 and CT1190B

CARsgen Announces Positive Clinical Data for Allogeneic CAR-T Products CT0596 and CT1190B

SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces clinical data for CT0596, an allogeneic BCMA-targeting CAR-T product...

TCT 2025 | Robot-Assisted PCI Enters a New Era: Results of the PANVIS STAR Multicenter Randomized Controlled Trial

TCT 2025 | Robot-Assisted PCI Enters a New Era: Results of the PANVIS STAR Multicenter Randomized Controlled Trial

SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- The 37th Annual Transcatheter Cardiovascular Therapeutics (TCT2025) symposium was held grandly in San Francisco, USA, attracting widespread attention from the global cardiovascular community. On the morning of...

GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine'

GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine'

YONGIN, South Korea, Nov. 3, 2025 /PRNewswire/ -- GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' have been...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 13
  • menu
    menu